Advertisement
Screener

Perrigo Company plc (PRGO) Increase (Decrease) in Accounts Receivable

2.8 / 5 stars · 68/120 Roast Me

Perrigo Company plc Increase (Decrease) in Accounts Receivable

Perrigo Company plc (PRGO) reported Increase (Decrease) in Accounts Receivable of $102.30 million for the 6-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05

  • Perrigo Company plc increase (decrease) in accounts receivable for the quarter ending 2026-06-27 was $9.80M.
  • Perrigo Company plc increase (decrease) in accounts receivable for the quarter ending 2026-03-28 was $92.50M, a 41.87% increase year-over-year.
  • Perrigo Company plc increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$26.10M.
  • Perrigo Company plc increase (decrease) in accounts receivable for the quarter ending 2025-09-27 was -$10.50M, a 120.19% decline year-over-year.
  • Perrigo Company plc increase (decrease) in accounts receivable for fiscal 2025 was -$30.70M, a 376.58% decline from fiscal 2024.
  • Perrigo Company plc increase (decrease) in accounts receivable for fiscal 2024 was $11.10M, a 80.56% decline from fiscal 2023.
  • Perrigo Company plc increase (decrease) in accounts receivable for fiscal 2023 was $57.10M.
  • Perrigo Company plc increase (decrease) in accounts receivable for fiscal 2022 was -$100.00K, a 100.06% decline from fiscal 2021.
Period endIncrease (Decrease) in Accounts Receivable 3 monthIncrease (Decrease) in Accounts Receivable 3 month as first filedIncrease (Decrease) in Accounts Receivable 6 monthIncrease (Decrease) in Accounts Receivable 6 month as first filedIncrease (Decrease) in Accounts Receivable 9 monthIncrease (Decrease) in Accounts Receivable 9 month as first filedIncrease (Decrease) in Accounts Receivable 12 monthIncrease (Decrease) in Accounts Receivable 12 month as first filed
2026-06-27$9.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$102.30M
10-Q · filed 2026-08-05
$76.20M
derived: sum of 3 quarters · filed 2026-08-05
$65.70M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-28$92.50M
10-Q · filed 2026-05-06
$66.40M
derived: sum of 2 quarters · filed 2026-05-06
$55.90M
derived: sum of 3 quarters · filed 2026-05-06
-$3.40M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$26.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$36.60M
derived: sum of 2 quarters · filed 2026-02-26
-$95.90M
derived: sum of 3 quarters · filed 2026-08-05
-$30.70M
10-K · filed 2026-02-26
2025-09-27-$10.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$69.80M
derived: sum of 2 quarters · filed 2026-08-05
-$4.60M
10-Q · filed 2025-11-05
-$62.80M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-28-$59.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$5.90M
10-Q · filed 2026-08-05
-$52.30M
derived: sum of 3 quarters · filed 2026-08-05
-$300.00K
derived: sum of 4 quarters · filed 2026-08-05
2025-03-29$65.20M
10-Q · filed 2026-05-06
$7.00M
derived: sum of 2 quarters · filed 2026-05-06
$59.00M
derived: sum of 3 quarters · filed 2026-05-06
$24.40M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$58.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$6.20M
derived: sum of 2 quarters · filed 2026-02-26
-$40.80M
derived: sum of 3 quarters · filed 2026-02-26
$11.10M
10-K · filed 2026-02-26
2024-09-28$52.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$17.40M
derived: sum of 2 quarters · filed 2025-11-05
$69.30M
10-Q · filed 2025-11-05
$55.80M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-29-$34.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
$17.30M
10-Q · filed 2025-08-06
$3.80M
derived: sum of 3 quarters · filed 2026-02-26
$1.90M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-30$51.90M
10-Q · filed 2025-05-07
$38.40M
derived: sum of 2 quarters · filed 2026-02-26
$36.50M
derived: sum of 3 quarters · filed 2026-02-26
$69.20M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$13.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$15.40M
derived: sum of 2 quarters · filed 2026-02-26
$17.30M
derived: sum of 3 quarters · filed 2026-02-26
$57.10M
10-K · filed 2026-02-26
2023-09-30-$1.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
$30.80M
derived: sum of 2 quarters · filed 2024-11-06
$70.60M
10-Q · filed 2024-11-06
$31.90M
derived: sum of 4 quarters · filed 2025-02-28
2023-07-01$32.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$72.50M
10-Q · filed 2024-08-02
$33.80M
derived: sum of 3 quarters · filed 2025-02-28
$16.00M
derived: sum of 4 quarters · filed 2025-02-28
2023-04-01$39.80M
10-Q · filed 2024-05-07
$1.10M
derived: sum of 2 quarters · filed 2025-02-28
-$16.70M
derived: sum of 3 quarters · filed 2025-02-28
$1.60M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31-$38.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
-$56.50M
derived: sum of 2 quarters · filed 2025-02-28
-$38.20M
derived: sum of 3 quarters · filed 2025-02-28
-$100.00K
10-K · filed 2025-02-28
2022-10-01-$17.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$500.00K
derived: sum of 2 quarters · filed 2023-11-07
$38.60M
10-Q · filed 2023-11-07
$16.00M
derived: sum of 4 quarters · filed 2024-02-27
2022-07-02$18.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$56.40M
10-Q · filed 2023-08-08
$33.80M
derived: sum of 3 quarters · filed 2024-02-27
$107.90M
derived: sum of 4 quarters · filed 2024-02-27
2022-04-02$38.10M
10-Q · filed 2023-05-09
$15.50M
derived: sum of 2 quarters · filed 2024-02-27
$89.60M
derived: sum of 3 quarters · filed 2024-02-27
$167.50M
derived: sum of 4 quarters · filed 2024-02-27
2021-12-31-$22.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
$51.50M
derived: sum of 2 quarters · filed 2024-02-27
$129.40M
derived: sum of 3 quarters · filed 2024-02-27
$159.70M
10-K · filed 2024-02-27
2021-10-02$74.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$152.00M
derived: sum of 2 quarters · filed 2022-11-08
$182.30M
10-Q · filed 2022-11-08
$119.80M
derived: sum of 4 quarters · filed 2023-02-28
2021-07-03$77.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$108.20M
10-Q · filed 2022-08-09
$45.70M
derived: sum of 3 quarters · filed 2023-02-28
$167.20M
derived: sum of 4 quarters · filed 2023-02-28
2021-04-03$30.30M
10-Q · filed 2022-05-11
-$32.20M
derived: sum of 2 quarters · filed 2023-02-28
$89.30M
derived: sum of 3 quarters · filed 2023-02-28
-$206.20M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$62.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$59.00M
derived: sum of 2 quarters · filed 2023-02-28
-$236.50M
derived: sum of 3 quarters · filed 2023-02-28
-$168.90M
10-K · filed 2023-02-28
2020-09-26$121.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$174.00M
derived: sum of 2 quarters · filed 2021-11-12
-$106.40M
10-Q · filed 2021-11-12
$22.20M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-27-$295.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11
-$227.90M
10-Q · filed 2021-08-11
-$99.30M
derived: sum of 3 quarters · filed 2022-03-01
-$142.50M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-28$67.60M
10-Q · filed 2021-05-12
$196.20M
derived: sum of 2 quarters · filed 2022-03-01
$153.00M
derived: sum of 3 quarters · filed 2022-03-01
$159.80M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$128.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$85.40M
derived: sum of 2 quarters · filed 2022-03-01
$92.20M
derived: sum of 3 quarters · filed 2022-03-01
$140.70M
10-K · filed 2022-03-01
2019-09-28-$43.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
-$36.40M
derived: sum of 2 quarters · filed 2020-11-05
$12.10M
10-Q · filed 2020-11-05
$11.30M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-29$6.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$55.30M
10-Q · filed 2020-08-05
$54.50M
derived: sum of 3 quarters · filed 2021-03-01
$10.00M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-30$48.50M
10-Q · filed 2020-05-05
$47.70M
derived: sum of 2 quarters · filed 2021-03-01
$3.20M
derived: sum of 3 quarters · filed 2021-03-01
$30.10M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$800.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$45.30M
derived: sum of 2 quarters · filed 2021-03-01
-$18.40M
derived: sum of 3 quarters · filed 2021-03-01
-$21.00M
10-K · filed 2021-03-01
2018-09-29-$44.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$17.60M
derived: sum of 2 quarters · filed 2019-11-06
-$20.20M
10-Q · filed 2019-11-06
$15.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$26.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$24.30M
10-Q · filed 2019-08-08
$59.50M
derived: sum of 3 quarters · filed 2020-02-27
$72.90M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$2.60M
10-Q · filed 2019-05-09
$32.60M
derived: sum of 2 quarters · filed 2020-02-27
$46.00M
derived: sum of 3 quarters · filed 2020-02-27
$44.30M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$35.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$48.60M
derived: sum of 2 quarters · filed 2020-02-27
$46.90M
derived: sum of 3 quarters · filed 2020-02-27
-$3.20M
10-K · filed 2020-02-27
2017-09-30$13.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$11.70M
derived: sum of 2 quarters · filed 2018-11-08
-$38.40M
10-Q · filed 2018-11-08
$75.20M
derived: sum of 4 quarters · filed 2019-02-27
2017-07-01-$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$51.80M
10-Q · filed 2018-08-09
$61.80M
derived: sum of 3 quarters · filed 2019-02-27
-$10.00M
derived: sum of 4 quarters · filed 2019-02-27
2017-04-01-$50.10M
10-Q · filed 2018-05-08
$63.50M
derived: sum of 2 quarters · filed 2019-02-27
-$8.30M
derived: sum of 3 quarters · filed 2019-02-27
-$32.20M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$113.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$41.80M
derived: sum of 2 quarters · filed 2019-02-27
$17.90M
derived: sum of 3 quarters · filed 2019-02-27
$600.00K
10-K · filed 2019-02-27
2016-10-01-$71.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
-$95.70M
derived: sum of 2 quarters · filed 2017-11-09
-$113.00M
10-Q · filed 2017-11-09
-$113.60M
10-Q · filed 2016-11-10
-$119.30M
derived: sum of 4 quarters · filed 2018-03-01
2016-07-02-$23.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
-$41.20M
10-Q · filed 2017-08-10
-$42.30M
10-Q · filed 2016-08-10
-$47.50M
derived: sum of 3 quarters · filed 2018-03-01
-$93.70M
derived: sum of 4 quarters · filed 2018-03-01
2016-04-02-$17.30M
10-Q · filed 2017-05-30
-$23.00M
10-Q · filed 2016-05-16
-$23.60M
derived: sum of 2 quarters · filed 2018-03-01
-$69.80M
derived: sum of 3 quarters · filed 2018-03-01
$10.20M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31-$6.30M
derived: 10-K 6 month − 10-Q 3 month · filed 2018-03-01
-$52.50M
10-K · filed 2018-03-01
-$86.10M
10-KT · filed 2016-02-25
$27.50M
derived: sum of 3 quarters · filed 2018-03-01
-$4.80M
derived: sum of 4 quarters · filed 2018-03-01
2015-09-26-$46.20M
10-Q · filed 2015-11-02
$33.80M
derived: sum of 2 quarters · filed 2017-05-22
$8.40M
10-Q/A · filed 2017-05-23
$30.90M
10-Q · filed 2016-11-10
$63.30M
derived: sum of 4 quarters · filed 2017-05-22
2015-06-27$80.00M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-05-22
$47.70M
10-Q/A · filed 2017-05-22
$77.20M
10-Q · filed 2016-08-10
$109.50M
derived: sum of 3 quarters · filed 2017-05-22
$51.10M
10-K · filed 2018-03-01
$81.70M
10-K · filed 2015-08-13
2015-03-28-$32.30M
10-Q/A · filed 2017-05-22
-$39.40M
10-Q · filed 2016-05-16
$29.50M
derived: sum of 2 quarters · filed 2017-05-22
-$34.90M
10-Q · filed 2015-04-29
$22.70M
derived: sum of 4 quarters · filed 2017-05-22
2014-12-27$61.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05
$4.50M
10-Q · filed 2015-02-05
$55.00M
derived: sum of 3 quarters · filed 2017-05-22
$79.90M
derived: sum of 4 quarters · filed 2017-05-22
2014-09-27-$57.30M
10-Q · filed 2015-11-02
-$6.80M
derived: sum of 2 quarters · filed 2017-05-22
$18.10M
derived: sum of 3 quarters · filed 2017-05-22
$37.50M
derived: sum of 4 quarters · filed 2017-05-22
2014-06-28$50.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-05-22
$75.40M
derived: sum of 2 quarters · filed 2017-05-22
$94.80M
derived: sum of 3 quarters · filed 2017-05-22
$140.50M
10-K · filed 2017-05-22
$226.70M
10-K · filed 2014-08-14
2014-03-29$24.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-29
$44.30M
derived: sum of 2 quarters · filed 2015-04-29
$90.00M
10-Q · filed 2015-04-29
$121.10M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-28$19.40M
derived: 10-Q 6 month − 8-K 3 month · filed 2015-02-05
$65.10M
10-Q · filed 2015-02-05
$96.20M
derived: sum of 3 quarters · filed 2016-02-25
$118.30M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-28$45.70M
8-K · filed 2014-11-20
$76.80M
derived: sum of 2 quarters · filed 2016-02-25
$98.90M
derived: sum of 3 quarters · filed 2016-02-25
2013-06-29$31.10M
derived: 10-KT 12 month − 10-Q 9 month · filed 2016-02-25
$53.20M
derived: sum of 2 quarters · filed 2016-02-25
$37.00M
10-KT · filed 2016-02-25
2013-03-30$22.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-07
$5.90M
10-Q · filed 2014-05-07
2012-12-29-$16.20M
10-Q · filed 2014-02-06
2012-06-30$49.30M
10-K · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Generate Biomedicines, Inc. (GENB)United States$2.052B
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38